• Alopecia(Cosmetics 1)
  • Alopecia(Cosmetics 2)
  • Alopecia(Drug)
  • Arthritis
  • NASH
  • Psoriasis
  • IBD
  • Me Ture
    • 1Q
    • 2Q
    • 3Q
    • 4Q
    • 1Q
    • 2Q
    • 3Q
    • 4Q
    • 1Q
    • 2Q
    • 3Q
    • 4Q
    • 1Q
    • 2Q
    • 3Q
    • 4Q
    • 1Q
    • 2Q
    • 3Q
    • 4Q
    • 1Q
    • 2Q
    • 3Q
    • 4Q
    • 1Q
    • 2Q
    • 3Q
    • 4Q
    • 1Q
    • 2Q
    • 3Q
    • 4Q
    • 1Q
    • 2Q
    • 3Q
    • 4Q
    • 1Q
    • 2Q
    • 3Q
    • 4Q
    • 1Q
    • 2Q
    • 3Q
    • 4Q
Screening of Natural sources
DEE
Process develop.
Formulation Study
Clinical Trials
Laun-
ching
POC
Efficacy Study
Fomulation & Analysis Study
Manufacturing & Stability
Clinical Trials
Laun-
ching
Marker & Active Substance ID
Nonclinical Study, CMC
P1(Topical)
P2(Topical)
P3(Topical)
NDA
Launching
Nonclinical Study, CMC
P1(Oral)
P2(Oral)
P3(Oral)
NDA
Pricing
Laun-
ching
Nonclinical Study
P3(Oral)
P3(Oral)
Nonclinical Study
P2(Oral)
P3(Oral)
Nonclinical Study
P2(Oral)